|  | Before peritonitis | 12 hours peritonitis | 18 hours peritonitis | 24 hours peritonitis |
---|---|---|---|---|---|
Portal vein flow (mL/kg/min) | Control | 18 (15 to 22) | 29 (21 to 31)b | 29 (24 to 34)b | 26 (24 to 30)b |
 | AVP | 18 (16 to 20) | 24 (20 to 31)b | 22 (16 to 27) | 20 (16 to 24) |
Hepatic artery flow (mL/kg/min) | Control | 1.7 (0.4 to 2.1) | 1.4 (0.9 to 2.9) | 1.6 (1.3 to 3.5) | 2.1 (1.1 to 3.6)b |
 | AVP | 0.6 (0.2 to 1.6) | 1.6 (0.2 to 3.2)b | 1.9 (0.3 to 3.3)b | 3.0 (0.3 to 5.5)b |
Hepatic O2 delivery (mL/kg/min) | Control | 1.0 (0.9 to 1.5) | 2.9 (2.5 to 3.7)b | 3.0 (2.0 to 3.5)b | 2.6 (1.8 to 3.1)b |
 | AVP | 1.2 (1.0 to 1.5) | 2.5 (1.9 to 3.0)b | 2.2 (1.7 to 3.0)b | 2.3 (1.4 to 2.7)b |
Portal vein O2 saturation (%) | Control | 58 (55 to 64) | 78 (76 to 81)b | 77 (71 to 79)b | 72 (67 to 74)b |
 | AVP | 60 (55 to 63) | 78 (68 to 83)b | 72 (65 to 75)b | 69 (63 to 71)b |
Hepatic vein O2 saturation (%) | Control AVP | 25 (24 to 72) | 63 (54 to 65)b | 58 (52 to 65)b | 53 (44 to 56)b |
 |  | 30 (20 to 55) | 66 (50 to 70)b | 54 (42 to 61)b | 55 (50 to 58)b |
Portal drained viscera O2 extraction (%) | Control AVP | 40 (37 to 46) | 21 (18 to 24)b | 21 (18 to 25)b | 27 (24 to 34)b |
 |  | 43 (37 to 44) | 22 (17 to 35)b | 22 (19 to 31)b | 30 (25 to 34)b |
Hepatic O2 uptake | Control | 0.6 (0.4 to 0.8) | 0.6 (0.4 to 0.9) | 0.7 (0.5 to 1.1) | 0.6 (0.4 to 0.8) |
(mL/kg/min) | AVP | 0.6 (0.5 to 0.9) | 0.8 (0.5 to 0.9) | 0.7 (0.4 to 1.0) | 0.5 (0.3 to 0.7) |
Portal vein | Control | 10 (9 to 12) | 14 (12 to 15) | 15 (13 to 17) | 16 (13 to 18)a |
lactate/pruvate ratio | AVP | 11 (10 to 12) | 13 (11 to 15) | 14 (13 to 15) | 15 (13 to 17)a |
Hepatic vein | Control | 9 (8 to 10) | 12 (10 to 15) | 13 (12 to 15) | 14 (12 to 18)a |
lactate/pruvate ratio | AVP | 8 (7 to 12) | 12 (10 to 15) | 11 (10 to 16) | 13 (11 to 16)a |
Portal vein pH | Control | 7.49 (7.46 to 7.52) | 7.46 (7.42 to 7.48) | 7.41 (7.38 to 7.45)b | 7.37 (7.33 to 7.42)b |
 | AVP | 7.48 (7.43 to 7.51) | 7.47 (7.44 to 7.49)b | 7.44 (7.39 to 7.47)b | 7.42 (7.37 to 7.43)b |
Hepatic vein pH | Control | 7.49 (7.47 to 7.53) | 7.48 (7.43 to 7.49) | 7.43 (7.40 to 7.46)b | 7.39 (7.33 to 7.44)b |
 | AVP | 7.49 (7.44 to 7.54) | 7.47 (7.44 to 7.50) | 7.43 (7.39 to 7.48)b | 7.44 (7.40 to 7.46) |
Portal vein base excess (mmol/L) | Control | 10.8 (9.5 to 12.5) | 10.2 (8.1 to 11.2)b | 6.5 (3.0 to 8.2)b | 4.8 (0.1 to 6.2)b |
 | AVP | 9.8 (7.8 to 12.4) | 9.2 (7.3 to 10.4) | 9.5 (6.0 to 10.6) | 8.9 (3.0 to 11.0)a |
Hepatic vein base excess (mmol/L) | Control | 12.6 (10.5 to 14.2) | 11.1 (7.9 to 12.2)b | 7.6 (5.1 to 8.9)b | 5.8 (0.5 to 7.4)b |
 | AVP | 11.6 (10.1 to 14.8) | 10.5 (8.5 to 12.2)b | 9.8 (4.5 to 11.1)b | 9.0 (3.8 to 11.8)b |
ICG plasma | Control | 20 (19 to 23) | 17 (13 to 31) | 14 (10 to 34) | 13 (8 to 22)b |
disappearance rate (%/min) | AVP | 15 (11 to 19) | 14 (10 to 18) | 13 (8 to 15) | 12 (12 to 15) |
Urine output (mL/kg/h) | Control | 5.4 (4.1 to 7.2) | 3.2 (2.3 to 4.8)b | ||
 | AVP | 6.7 (5.9 to 8.0) | 5.6 (4.6 to 8.6)a | ||
Creatinine clearance (mL/min) | Control | 80 (67 to 88) | 64 (35 to 85)c | ||
 | AVP | 79 (60 to 98) | 61 (44 to 73)c | ||
Fractional Na+ excretion (%) | Control AVP | 5.6 (4.8 to 7.7) | 3.0 (2.5 to 5.1) | ||
 |  | 8.3 (6.4 to 10.0)a | 9.5 (7.2 to 10.7)a |